GSK-3 and Tau: a key duet in Alzheimer's disease
CL Sayas, J Ávila - Cells, 2021 - mdpi.com
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
L Wang, J Li, L Di - Medicinal Research Reviews, 2022 - Wiley Online Library
Abstract Glycogen synthase kinase‐3 (GSK3) is a highly evolutionarily conserved
serine/threonine protein kinase first identified as an enzyme that regulates glycogen …
serine/threonine protein kinase first identified as an enzyme that regulates glycogen …
Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications
T Liu, YF Lv, JL Zhao, QD You, ZY Jiang - Free Radical Biology and …, 2021 - Elsevier
The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) participates in the
activation of the antioxidant cytoprotective pathway and other important physiological …
activation of the antioxidant cytoprotective pathway and other important physiological …
Small-molecule modulation of protein homeostasis
GM Burslem, CM Crews - Chemical reviews, 2017 - ACS Publications
Control of protein levels by nucleic-acid-based technologies has proven to be a useful
research tool but lacks the advantages of small molecules with respect to cell permeability …
research tool but lacks the advantages of small molecules with respect to cell permeability …
GSK-3: functional insights from cell biology and animal models
O Kaidanovich-Beilin, JR Woodgett - Frontiers in molecular …, 2011 - frontiersin.org
Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved
serine/threonine protein kinase encoded in mammals by two genes that generate two …
serine/threonine protein kinase encoded in mammals by two genes that generate two …
The therapeutic target Hsp90 and cancer hallmarks
Y Miyata, H Nakamoto, L Neckers - Current pharmaceutical …, 2013 - ingentaconnect.com
Hsp90 is a major molecular chaperone that is expressed abundantly and plays a pivotal role
in assisting correct folding and functionality of its client proteins in cells. The Hsp90 client …
in assisting correct folding and functionality of its client proteins in cells. The Hsp90 client …
Glycogen synthase kinase 3: a kinase for all pathways?
P Patel, JR Woodgett - Current topics in developmental biology, 2017 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK-3) is an unusual protein-serine kinase in that it is
primarily regulated by inhibition and lies downstream of multiple cell signaling pathways …
primarily regulated by inhibition and lies downstream of multiple cell signaling pathways …
[HTML][HTML] Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling
Summary The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced
chromosomal translocation (1; 11)(q42; q14. 3) in a Scottish family with a high incidence of …
chromosomal translocation (1; 11)(q42; q14. 3) in a Scottish family with a high incidence of …
DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II
B Steurer, RC Janssens, ME Geijer… - Nature …, 2022 - nature.com
The precise regulation of RNA Polymerase II (Pol II) transcription after genotoxic stress is
crucial for proper execution of the DNA damage-induced stress response. While stalling of …
crucial for proper execution of the DNA damage-induced stress response. While stalling of …
GSK-3 inhibitors: preclinical and clinical focus on CNS
H Eldar-Finkelman, A Martinez - Frontiers in molecular neuroscience, 2011 - frontiersin.org
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has
become an important strategy for treating neurodegenerative and psychiatric disorders. The …
become an important strategy for treating neurodegenerative and psychiatric disorders. The …